• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities - Product Image

Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities

  • ID: 2234841
  • September 2012
  • Greystone Associates

As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain is increasing and placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. Responding to this trend, drug developers are increasingly turning to transdermal formulations of pain management drugs. Because it has the potential to improve drug therapy compliance, transdermal delivery addresses a key healthcare issue – one that is particularly problematic in aging populations and developing economies. Currently approved transdermal pain products include narcotics, NSAIDs, and topical anesthetics. These patches and gels will encounter competition from development-stage transdermal formulations for a number of pain medications presently being marketed in oral or parenteral form. Several of these development programs involve international partnerships designed to take advantage of perceived opportunities in regional markets.

Highlights

- Analyzes and evaluates the global market opportunity for transdermal pain management and assesses the probable impact of evolving regulatory, economic and demand factors
- Assesses transdermal products approved or in development for the delivery of therapeutic pain management drugs
- Provides detailed descriptions of pain management treatment segments, market factors, and business strategies
- Forecasts transdermal pain management product demand to 2016 by geographic region and product segment
- Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners

Executive Summary

Scope and Definitions
The Current Pain Management Picture
Unmet Needs in Pain Management
The Opportunity for Transdermal Delivery of Pain Drugs

The Pain Management Market Opportunity

Evolution in Pain Management Guidelines
Regional Factors in Pain Management Practice
Pain Management Demand Drivers
Competitive Landscape
Factors Limiting Growth

Transdermal Drug Delivery Dynamics

Transdermal Pain Management Patches
Pain Patch Technology & Architectures
Transdermal Patch Manufacturing and Packaging
Patch Economics
Passive vs Active Delivery Systems
Transdermal Pain Management Gels
Transdermal Formulations
IP and Proprietary Technology
Limitations of Topical Gels

Transdermal Pain Management Product Assessments and Market Prospects

FDA Approved Transdermal Pain Management Products
Narcotic
NSAIDs
Local Anesthetic
Non-FDA Approved Commercial Transdermal Pain Management Products
Narcotic
NSAIDs
Local Anesthetic
Development-Stage Transdermal Pain Management Products
Narcotic
NSAID
Other Drug Classes

Transdermal Pain Management Market Factors

Regional Regulations
Clinical Trials
Quality and Reliability
Indications Prescribing Guidelines and Off-Label Prescribing
Managed Care and Payor Initiatives
Rx-to-OTC Switching
Skin Patch Revenue Models

Market Forecasts

Forecasts by Region
Forecasts by Drug Class
Forecasts by Delivery Form Factor
Market Share Data

Market Participant Profiles

Question Is this a U.S. report only, or does this report include global information?
Answer This report is global in scope and includes market data and forecasts by region and by drug class.
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos